Finance 28 May 2026 - 29 May 2026

XCHG Stock Edges Higher After Hours as EV-Charging Investors Search for a Catalyst

XCHG Stock Edges Higher After Hours as EV-Charging Investors Search for a Catalyst

XCHG Limited’s Nasdaq-listed ADS rose 2.76 cents to $0.6907 in late U.S. trading Thursday on volume of 6,971 shares, with no new company news in the past two days. The move followed a 40.5% drop in 2025 revenue and a widened net loss, as reported in XCHG’s annual filing. The company cited trade-policy uncertainty for deferred orders. Broader markets hit record highs, but EV-charging peers showed mixed moves.
May 29, 2026
GlobalFoundries shares to watch after Mubadala sells 22 million shares

GlobalFoundries shares to watch after Mubadala sells 22 million shares

GlobalFoundries shares fell 0.5% to $80.63 in after-hours trading Thursday after Mubadala sold 22 million shares, cutting its stake to 73%. Trading volume hit about 9.6 million, with the company’s market cap near $44.5 billion. The sale followed a 9.8% drop Wednesday after reports Mubadala aimed to raise $1.91 billion in a block trade. GlobalFoundries’ second-quarter revenue outlook topped Wall Street estimates.
May 29, 2026
Amdocs Stock Ticks Up While Nasdaq Hits New Highs; This Is the Filing Traders Are Watching

Amdocs Stock Ticks Up While Nasdaq Hits New Highs; This Is the Filing Traders Are Watching

Amdocs closed at $61.65, up 0.6%, after reporting second-quarter revenue of $1.172 billion, a 3.9% increase from last year. Net income fell to $138.8 million from $164.0 million, with diluted EPS down to $1.28 from $1.45. The company repurchased $138 million in shares and gave third-quarter revenue guidance of $1.155 billion to $1.195 billion. Trading volume reached about 908,000 shares.
May 29, 2026
Binah Capital Shares Dip in Late Trade as Investors Look Again at $29 Billion Assets

Binah Capital Shares Dip in Late Trade as Investors Look Again at $29 Billion Assets

Binah Capital shares closed at $1.62, down 5 cents, with fewer than 40,000 shares traded after Nasdaq’s regular session ended. The firm reported first-quarter advisory and brokerage assets of $29.0 billion, up 12.9% from last year. Quarterly revenue slipped 0.5% to $48.7 million, while net income rose to $1.9 million. Market cap stood at $27.4 million, far below larger industry peers.
May 29, 2026
Apogee Stock in Focus After Blackstone Announces $1.3 Billion Deal

Apogee Stock in Focus After Blackstone Announces $1.3 Billion Deal

Apogee Therapeutics secured up to $1.3 billion in funding from Blackstone Life Sciences to advance its eczema drug zumilokibart through late-stage trials. Shares closed nearly flat at $77.82 after earlier declines on drug data. In a Phase 2 trial, 65.9% of patients on the mid dose reached the main efficacy target. The company plans to move the mid dose into Phase 3 in late 2026.
May 29, 2026
Morningstar Shares Gain; Major Holders Raise Concerns Over Key Risk

Morningstar Shares Gain; Major Holders Raise Concerns Over Key Risk

Morningstar shares rose 1.9% to $180.11 in late after-hours trading Thursday, outpacing the S&P 500 ETF’s 0.6% gain. The company posted first-quarter revenue of $644.8 million, up 10.8%, and a 50% jump in diluted EPS to $2.73. Investors focused on Morningstar’s recent work with global asset owners and its expanded index business after acquiring CRSP in February.
May 29, 2026
eBay Bounces Back; Focus Turns to GameStop Moves

eBay Bounces Back; Focus Turns to GameStop Moves

eBay shares rose 1.6% to $112.13 Thursday after rejecting GameStop CEO Ryan Cohen’s $56 billion takeover bid. GameStop’s $125-a-share offer remains far above eBay’s trading price, reflecting investor doubts. eBay’s board called the bid “neither credible nor attractive” and cited financing concerns. GameStop disclosed direct ownership of 25,000 eBay shares and economic exposure to 29.1 million more through derivatives.
May 28, 2026
American Coastal Shares Slide as Hurricane-Risk Concerns Return

American Coastal Shares Slide as Hurricane-Risk Concerns Return

American Coastal Insurance closed down 1.7% at $10.52 Thursday, underperforming the Russell 2000’s 0.6% gain. The company reported Q1 net income of $19.3 million, down from $21.3 million a year earlier, with gross written premiums falling 24.5%. Shares traded between $10.42 and $10.75 on volume near 281,000. The firm renewed its main catastrophe reinsurance program, raising its limit to $1.918 billion.
May 28, 2026
POLE Stock Is Quiet. Andretti Acquisition II’s September Deadline Is Not

POLE Stock Is Quiet. Andretti Acquisition II’s September Deadline Is Not

Andretti Acquisition Corp. II’s Class A shares (POLE) closed at $10.71 on Thursday, down 0.3% with just 3,504 shares traded. The company, a SPAC, faces a Sept. 9 deadline to complete a business combination or risk liquidation, with filings citing “substantial doubt” about its ability to continue. Its planned merger with StoreDot was terminated in February. Andretti reported $246.4 million in its trust account as of March 31.
May 28, 2026
Apyx Medical Shares Rise 6% as Body-Contouring Push Hits New Milestone

Apyx Medical Shares Rise 6% as Body-Contouring Push Hits New Milestone

Apyx Medical shares rose 6.4% to $4.15 Thursday after highlighting its AYON body-contouring device and announcing a return to Miami Swim Week. The company reported Q1 revenue of $12.5 million, up from $9.4 million, and narrowed its net loss to $2.1 million. Apyx received expanded FDA clearance for AYON in May and faces competition from Solta Medical and MicroAire. The company warned of possible future losses and shareholder dilution.
May 28, 2026
Newell Brands Stock Just Slid Again — Why the Sharpie Maker’s Turnaround Is Being Tested

Newell Brands Stock Just Slid Again — Why the Sharpie Maker’s Turnaround Is Being Tested

Newell Brands shares fell about 4% Thursday afternoon to $3.515, underperforming broad U.S. market gains. The drop follows a brief rebound and comes ahead of Friday’s dividend record date. Investors remain cautious despite a raised 2026 outlook, citing weak sales, high debt, and unresolved tariff refunds. Trading volume stayed below average as the stock continued to lag sector peers.
May 28, 2026
BeOne Dips on Wall Street After Cancer Results, Market Looks On

BeOne Dips on Wall Street After Cancer Results, Market Looks On

BeOne Medicines shares fell 2.7% to $291.98 Thursday afternoon despite positive late-stage cancer trial data, while the Nasdaq Biotechnology Index rose 1.1%. The Phase 3 HERIZON-GEA-01 trial showed BeOne’s ZIIHERA combo reached median overall survival of 26.4 months versus 19.2 months for the control. Investors appeared cautious ahead of more data expected at the ASCO meeting next week.
May 28, 2026
Solid Power Shares on the Move Again; Battery Bulls Eye $3.40

Solid Power Shares on the Move Again; Battery Bulls Eye $3.40

Solid Power shares traded at $3.40, up 1.2% Thursday afternoon on the Nasdaq, with volume near 4 million and market cap around $739 million. Investors watched updates on SK On work and cash position, as the company reported $3.1 million in Q1 revenue and $435.3 million in liquidity. Peers QuantumScape and SES AI also rose. Solid Power focuses on selling solid electrolyte material and licensing its battery tech.
May 28, 2026
Viking Therapeutics Stock Draws Wall Street Attention with Obesity Pill Competition Growing

Viking Therapeutics Stock Draws Wall Street Attention with Obesity Pill Competition Growing

Viking Therapeutics shares rose 1.7% to $32.19 after Lake Street initiated coverage with a Buy rating and an $89 price target, citing potential for its obesity drug VK2735. Phase 2 trial data showed up to 12.2% mean weight loss in 13 weeks. The company’s market cap stood at $3.72 billion. Board elections and auditor approval were disclosed in a May 26 SEC filing.
May 28, 2026
1 2 3 209

Stock Market Today

  • Light & Wonder Extends Buy-Back of ASX CHESS Depositary Interests
    May 28, 2026, 7:58 PM EDT. Light & Wonder Inc., a gaming and entertainment company, has extended its on-market buy-back of ASX CHESS Depositary Interests (CDIs), representing its shares. The buy-back aims to repurchase company stock directly from investors on the Australian Securities Exchange, potentially supporting share price stability. This move follows recent strategic initiatives by the company to optimize capital structure and return value to shareholders. Investors should monitor ongoing buy-back activity for impacts on LIght & Wonder's market performance.